The innovative system merges two previously separate streams of biological data: gene activity at the single-cell level and know interactions between genes.
The stent hadn’t helped after all; the impacted kidney had, in fact, been irreversibly damaged and was now functioning at a paltry 20%. Why? The cancer was back, and worse.
WATCH: Prof. Ben-David shares the groundbreaking insights regarding cancer biology and treatment strategies.
‘The words ‘Making the impossible possible’ are inscribed on my desk. That’s what Make-A-Wish is all about,” says Denise Bar-Aharon, co-founder and CEO of Make-A-Wish Israel.
Amid the sea of collective pain that we navigate as a nation, life is a gift worth cherishing every single day.
The researchers developed nanoparticles, which dissolve into water and carbon dioxide within a month, to encapsulate two different cancer- fighting drugs.
“I’ve always found the Israeli-man-with-the-shaved-head look to be very sexy,” my wife, Jody, said.
Israel has seen a significant annual decrease of 2-3% in the incidence of colorectal cancer among women and men.
Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.
Discover the revolution in CLL treatment: Dr. Evelyn Shabad and Carol Gilad share insights on follow-up, short-term treatment, and surprising results without major side effects.
JPOST Digital Library
